Download Mendeleytrans-(3S,4S)-Disubstituted pyrrolidines as inhibitors of the human aspartyl protease renin. Part I: Prime site exploration using an amino linker.
Lorthiois, E., Cumin, F., Ehrhardt, C., Kosaka, T., Sellner, H., Ostermann, N., Francotte, E., Wagner, T., Maibaum, J.(2015) Bioorg Med Chem Lett 25: 1782-1786
- PubMed: 25782742
- DOI: https://doi.org/10.1016/j.bmcl.2015.02.039
- Primary Citation of Related Structures:
4RYC, 4RYG - PubMed Abstract:
Recently, we reported on the discovery of (3S,4S)-disubstituted pyrrolidines (e.g., 2) as inhibitors of the human aspartyl protease renin. In our effort to further expand the scope of this novel class of direct renin inhibitors, a new sub-series was designed in which the prime site substituents are linked to the pyrrolidine core by a (3S)-amino functional group. In particular, analogs bearing the corresponding sulfonamide spacer (50, 51 and 54a) demonstrated a pronounced increase in in vitro potency compared to compound 2.
Organizational Affiliation:
Novartis Pharma AG, Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland. Electronic address: edwige.lorthiois@novartis.com.
